Article
Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy.
Pediatric pulmonology - 1 Feb 2022
Lahiri Thomas, Sullivan Jillian S
Abstract excerpt
Highly effective modulator therapy (HEMT) for cystic fibrosis (CF) has been touted as one of the greatest advances to date in CF care. As these therapies are now available for many older children and adults with CF, marked improvement of their nutritional status, pulmonary and gastrointestinal symptoms has been observed. However, most infants and younger children are not current candidates for HEMT due to age...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
